Translational Cancer Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 29.4% | 0.524 | Q2 | 62.6% |
| 2024 | 1.7 | Q4 | 20.9% | 0.521 | Q2 | 63.6% |
| 2023 | 1.5 | Q4 | 19.8% | 0.422 | Q3 | 59.4% |
| 2022 | 0.9 | Q4 | 11.9% | 0.247 | Q3 | 44.6% |
| 2021 | 0.5 | Q4 | 26.1% | 0.185 | Q4 | 36.5% |
| 2020 | — | — | 0.254 | Q4 | 44.7% | |
| 2019 | — | — | 0.312 | Q3 | 53.6% | |
| 2018 | — | — | 0.378 | Q3 | 57.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2218-676X
ISSN
2219-6803
country
HKcoverage
2012-2026